Drug Type Virus-like Drug Conjugates (VDCs) |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Meletios Therapeutics SASStartup |
Active Organization Meletios Therapeutics SASStartup |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Coronaviridae Infections | Phase 1 | FR | Meletios Therapeutics SASStartup | 28 Jun 2023 |
Dengue | Preclinical | FR | Meletios Therapeutics SASStartup | 28 Jun 2023 |
Influenza A virus infection | Preclinical | FR | Meletios Therapeutics SASStartup | 28 Jun 2023 |
Henipavirus Infections | Discovery | FR | Meletios Therapeutics SASStartup | 23 Apr 2024 |